ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article
Kim A. Eagle(University of Michigan), Joseph P. Ornato, Raymond J. Gibbons(Mayo Clinic), Alice K. Jacobs(Boston Medical Center), Gordon A. Ewy(University of Arizona), L. David Hillis, Robert A. Marlow, Loren F. Hiratzka(Bethesda North Hospital), Sidney C. Smith(University of North Carolina at Chapel Hill), Howard C. Herrmann(University of Pennsylvania), Valentı́n Fuster(Mount Sinai Hospital), Robert A. Guyton(Emory University), Ravin Davidoff, Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), Jeffrey L. Anderson(Intermountain Medical Center), James Hart, Timothy J. Gardner(Christiana Care Health System), Joseph S. Alpert(University of Arizona), Thomas A. Orszulak, Bruce W. Lytle(Heart Hospital Baylor Plano), William C. Nugent, Adolph M. Hutter, Sharon A. Hunt, David P. Faxon(Memorial Hermann), Fred H. Edwards(Edwards (United Kingdom)), Gabriel Gregoratos, Elliott M. Antman(Brigham and Women's Hospital)
Cited by 230
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.1k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k